Karmanos Cancer Institute at Mclaren Greater Lansing — Lansing, Michigan

Karmanos Cancer Institute at Mclaren Greater Lansing is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute at Mclaren Greater Lansing has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndromes, Cytopenia.

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute at Mclaren Greater Lansing?

Karmanos Cancer Institute at Mclaren Greater Lansing has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute at Mclaren Greater Lansing conducted?

Karmanos Cancer Institute at Mclaren Greater Lansing has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndromes, Cytopenia.

Is Karmanos Cancer Institute at Mclaren Greater Lansing accredited by Crixeo Health?

Karmanos Cancer Institute at Mclaren Greater Lansing has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute at Mclaren Greater Lansing?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.